Carlos E Ibanez

This inventor holds 8 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Chiron Corporation, Novartis Vaccines & Diagnostics, Gmbh, Denovo Biopharma LLC. Active years: 1998-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos E Ibanez. Retrieved from https://idiyas.com/inventor/carlos-e-ibanez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 62.5

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 437(Granted Patents)

Company Filing History:

Novartis Vaccines & Diagnostics, Gmbh

Years Active: 1998-2021

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11060112 - Producer cells for replication competent retroviral vectors (2021-07-13),

2. 10316333 - Producer cells for replication competent retroviral vectors (2019-06-11),

3. 7977091 - Eukaryotic layered vector initiation systems (2011-07-12),

4. 7572628 - Eukaryotic layered vector initiation systems (2009-08-11),

5. 6818439 - Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders (2004-11-16),

6. 6376236 - Recombinant alphavirus particles (2002-04-23),

7. 5843723 - Alphavirus vector constructs (1998-12-01),

8. 5789245 - Alphavirus structural protein expression cassettes (1998-08-04),

Title: Carlos E. Ibanez: Innovator in Gene Therapy

Introduction

Carlos E. Ibanez is a prominent inventor based in San Diego, California. He has made significant contributions to the field of gene therapy, holding a total of eight patents. His work focuses on the development of innovative methods and cell lines for producing viral vectors that are essential for gene therapy applications.

Latest Patents

Among his latest patents, Carlos has developed producer cells for replication competent retroviral vectors. These patents disclose cell lines and methods for the production of vectors and viral particles that are useful in gene therapy. His innovative approaches have the potential to enhance the effectiveness of gene therapy treatments.

Career Highlights

Carlos has had a distinguished career, working with notable companies such as Chiron Corporation and Novartis Vaccines & Diagnostics GmbH. His experience in these organizations has allowed him to contribute to groundbreaking advancements in the field of biotechnology and pharmaceuticals.

Collaborations

Throughout his career, Carlos has collaborated with esteemed colleagues, including Douglas J. Jolly and Thomas W. Dubensky, Jr. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective fields.

Conclusion

Carlos E. Ibanez is a key figure in the realm of gene therapy, with a strong portfolio of patents and a history of impactful collaborations. His work continues to influence the development of innovative therapies that hold promise for the future of medicine.

Profile summary based on public USPTO records.